Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Indivior Total Liabilities 2012-2025 | INDV

Indivior total liabilities from 2012 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Indivior Annual Total Liabilities
(Millions of US $)
2024 $1,668
2023 $1,951
2022 $1,718
2021 $1,629
2020 $1,449
2019 $1,443
2018 $1,481
2017 $1,647
2016 $1,504
2015 $1,216
2014 $1,222
2013 $492
2012 $412
2011 $305
Indivior Quarterly Total Liabilities
(Millions of US $)
2025-09-30 $1,623
2025-06-30 $1,709
2025-03-31 $1,660
2024-12-31 $1,652
2024-09-30 $1,631
2024-06-30 $1,656
2024-03-31 $1,443
2023-12-31 $1,951
2023-09-30 $1,876
2023-06-30 $1,614
2023-03-31 $1,683
2022-12-31 $1,718
2022-09-30 $1,444
2022-06-30 $1,490
2022-03-31 $1,492
2021-12-31 $1,629
2021-09-30 $1,539
2021-06-30 $1,438
2021-03-31 $1,447
2020-12-31 $1,449
2020-09-30 $1,467
2020-06-30 $1,493
2020-03-31 $1,473
2019-12-31 $1,443
2019-09-30 $1,338
2019-06-30 $1,363
2019-03-31 $1,472
2018-12-31 $1,481
2018-09-30 $1,507
2018-06-30 $1,625
2018-03-31 $1,600
2017-12-31 $1,647
2017-09-30 $1,441
2017-06-30 $1,462
2017-03-31 $1,436
2016-12-31 $1,504
2016-09-30 $1,471
2016-06-30 $1,240
2016-03-31 $1,253
2015-12-31 $1,216
2015-09-30 $1,267
2015-06-30 $1,292
2015-03-31 $0
2014-12-31
2014-09-30 $0
2014-06-30 $0
2013-12-31 $492
2012-12-31 $412
2011-12-31 $305
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $1.188B
Indivior PLC operates as a specialty pharmaceutical company. It is engaged in discovering and developing medications and treatment for alcohol addiction, opioid overdose, cocaine intoxication and co-occurring conditions, such as schizophrenia. The Company markets and promotes SUBOXONE (buprenorphine and naloxone) Sublingual Film, SUBOXONE (buprenorphine and naloxone) Sublingual Tablet, and SUBUTEX (buprenorphine) Sublingual Tablet, each buprenorphine-based treatment for opioid. Indivior PLC is based in United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $75.529B 28.69
Zoetis (ZTS) United States $53.099B 19.00
Takeda Pharmaceutical (TAK) Japan $43.243B 8.82
Daiichi Sankyo, - (DSNKY) Japan $42.092B 20.96
BeOne Medicines - (ONC) Switzerland $35.245B 0.00
Sandoz Group AG (SDZNY) Switzerland $29.520B 0.00
United Therapeutics (UTHR) United States $19.266B 16.95
Merck (MKKGY) Germany $16.414B 10.67
Neurocrine Biosciences (NBIX) United States $15.330B 36.78
Shionogi (SGIOY) Japan $14.275B 13.11
Summit Therapeutics (SMMT) United States $13.935B 0.00
Ionis Pharmaceuticals (IONS) United States $12.096B 0.00
IPSEN (IPSEY) France $12.095B 0.00
Madrigal Pharmaceuticals (MDGL) United States $10.808B 0.00
Orion OYJ (ORINY) Finland $9.208B 26.31
Eisai (ESAIY) $8.260B 0.00
Corcept Therapeutics (CORT) United States $8.063B 87.10
Stevanato Group S.p.A (STVN) Italy $7.571B 44.64
Grifols, S.A (GRFS) Spain $5.934B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.730B 17.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.142B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.294B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.005B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.672B 17.45
Centessa Pharmaceuticals (CNTA) United Kingdom $3.016B 0.00
Dyne Therapeutics (DYN) United States $2.973B 0.00
Hypermarcas (HYPMY) Brazil $2.936B 22.07
Catalyst Pharmaceuticals (CPRX) United States $2.617B 8.38
Soleno Therapeutics (SLNO) United States $2.517B 0.00
Ocular Therapeutix (OCUL) United States $2.303B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.905B 22.58
Avadel Pharmaceuticals (AVDL) Ireland $1.841B 0.00
Guardian Pharmacy Services (GRDN) United States $1.836B 0.00
Xeris Biopharma Holdings (XERS) United States $1.594B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.510B 89.62
Ardelyx (ARDX) United States $1.446B 0.00
Harrow (HROW) United States $1.311B 0.00
Evotec AG (EVO) Germany $1.188B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.181B 0.00
Oruka Therapeutics (ORKA) United States $1.134B 0.00
Collegium Pharmaceutical (COLL) United States $1.129B 6.17
Relay Therapeutics (RLAY) United States $1.129B 0.00
Enliven Therapeutics (ELVN) United States $1.096B 0.00
Nektar Therapeutics (NKTR) United States $1.032B 0.00
Xencor (XNCR) United States $1.025B 0.00
Cronos Group (CRON) Canada $0.938B 0.00
ARS Pharmaceuticals (SPRY) United States $0.894B 0.00
ProKidney (PROK) United States $0.795B 0.00
Theravance Biopharma (TBPH) United States $0.753B 62.29
Savara (SVRA) United States $0.697B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.687B 6.13
Elite Pharmaceuticals (ELTP) United States $0.660B 0.00
Bioventus (BVS) United States $0.610B 12.51
Siga Technologies (SIGA) United States $0.604B 7.46
Aquestive Therapeutics (AQST) United States $0.598B 0.00
Esperion Therapeutics (ESPR) United States $0.593B 0.00
Zevra Therapeutics (ZVRA) United States $0.565B 0.00
Akebia Therapeutics (AKBA) United States $0.562B 0.00
KalVista Pharmaceuticals (KALV) United States $0.555B 0.00
Organogenesis (ORGO) United States $0.504B 0.00
4D Molecular Therapeutics (FDMT) United States $0.491B 0.00
Lexeo Therapeutics (LXEO) United States $0.443B 0.00
USANA Health Sciences (USNA) United States $0.373B 10.41
Galectin Therapeutics (GALT) United States $0.363B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.335B 51.50
Altimmune (ALT) United States $0.331B 0.00
Lyell Immunopharma (LYEL) United States $0.318B 0.00
Korro Bio (KRRO) United States $0.304B 0.00
Aldeyra Therapeutics (ALDX) United States $0.295B 0.00
Larimar Therapeutics (LRMR) United States $0.267B 0.00
Achieve Life Sciences (ACHV) Canada $0.252B 0.00
Nature's Sunshine Products (NATR) United States $0.249B 16.24
Aclaris Therapeutics (ACRS) United States $0.245B 0.00
Pyxis Oncology (PYXS) United States $0.243B 0.00
Journey Medical (DERM) United States $0.233B 0.00
AleAnna (ANNA) United States $0.217B 0.00
Avalo Therapeutics (AVTX) United States $0.216B 0.00
OmniAb (OABI) United States $0.205B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
MediWound (MDWD) Israel $0.201B 0.00
China SXT Pharmaceuticals (SXTC) China $0.193B 0.00
Profound Medical (PROF) Canada $0.177B 0.00
Protara Therapeutics (TARA) United States $0.171B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.159B 0.00
Cassava Sciences (SAVA) United States $0.147B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.134B 0.00
Incannex Healthcare (IXHL) Australia $0.131B 0.00
Inhibikase Therapeutics (IKT) United States $0.127B 0.00
Cardiol Therapeutics (CRDL) Canada $0.108B 0.00
Surrozen (SRZN) United States $0.106B 0.00
Context Therapeutics (CNTX) United States $0.101B 0.00
Champions Oncology (CSBR) United States $0.094B 34.00
Avita Medical (RCEL) United States $0.093B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
Metagenomi (MGX) United States $0.085B 0.00
Relmada Therapeutics (RLMD) United States $0.083B 0.00
Unicycive Therapeutics (UNCY) United States $0.081B 0.00
Prelude Therapeutics (PRLD) United States $0.079B 0.00
Dominari Holdings (DOMH) United States $0.078B 0.00
VAXART, INC (VXRT) United States $0.076B 0.00
Assertio Holdings (ASRT) United States $0.072B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.071B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
BioNxt Solutions (BNXTF) Canada $0.069B 0.00
Gain Therapeutics (GANX) United States $0.066B 0.00
Lite Strategy (LITS) United States $0.066B 0.00
Acrivon Therapeutics (ACRV) United States $0.064B 0.00
PolyPid (PYPD) Israel $0.060B 0.00
Talphera (TLPH) United States $0.059B 0.00
Wellgistics Health (WGRX) United States $0.059B 0.00
Fractyl Health (GUTS) United States $0.057B 0.00
Plus Therapeutics (PSTV) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.053B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Jupiter Neurosciences (JUNS) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
Karyopharm Therapeutics (KPTI) United States $0.046B 0.00
Telomir Pharmaceuticals (TELO) United States $0.045B 0.00
FibroGen (FGEN) United States $0.044B 0.00
Tempest Therapeutics (TPST) United States $0.044B 0.00
Inotiv (NOTV) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Liminatus Pharma (LIMN) United States $0.035B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.035B 29.12
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.033B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
SCYNEXIS (SCYX) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Cosmos Health (COSM) United States $0.022B 0.00
Vyome Holdings (HIND) United States $0.022B 0.00
Mangoceuticals (MGRX) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Heatwurx (PCSA) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Ainos (AIMD) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.02
BioLineRx (BLRX) Israel $0.015B 0.00
Lipocine (LPCN) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
BioVie (BIVI) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Lyra Therapeutics (LYRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
NewcelX (NCEL) Switzerland $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00